# A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis

> **NCT04682639** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 108 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Etrasimod
- **DRUG:** Placebo
- **DRUG:** Etrasimod

## Key facts

- **NCT ID:** NCT04682639
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-15
- **Primary completion:** 2022-09-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2024-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04682639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04682639, "A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04682639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*